✦ LIBER ✦

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors

✍ Scribed by Toshiaki Saeki; Shigemitsu Takashima; Masanori Terashima; Atsushi Satoh; Masakazu Toi; Akihiko Osaki; Tetsuya Toge; Shinji Ohno; Naohiro Nomura; Yoshio Fukuyama; Wasaburo Koizumi; Tetsuo Taguchi

Publisher: Springer
Year: 2005
Tongue: English
Weight: 229 KB
Volume: 10
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-004-0460-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tesetaxel, a new oral taxane, in combina

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

✍ Muhammad Wasif Saif; John Sarantopoulos; Amita Patnaik; Anthony W. Tolcher; Chri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

A Phase I study of 9-nitrocamptothecin g

A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

✍ M. Dror Michaelson; David P. Ryan; Charles S. Fuchs; Jeffrey G. Supko; Rocio Gar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## BACKGROUND 9‐Nitrocamptothecin (9‐NC) is an orally available camptothecin analog with antineoplastic activity that results from the inhibition of DNA topoisomerase I. Previous studies have suggested that it has significant clinical efficacy. The primary toxicities of 9‐NC include ga

Phase 1 study of the investigational, or

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB

Phase I trial of oral MAC-321 in subject

Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors

✍ A. C. Lockhart; R. Bukowski; M. L. Rothenberg; K. K. Wang; W. Cooper; J. Grover; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 212 KB

Phase I study of weekly (day 1 and 8) do

Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies

✍ Ramesh K. Ramanathan; Sakkaraiappan Ramalingam; Merrill J. Egorin; Chandra P. Be 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 227 KB

A phase I study of intermittent infusion

A phase I study of intermittent infusion cladribine in patients with solid tumors

✍ Ken Kobayashi; Nicholas J. Vogelzang; Sheila M. O'Brien; Richard L. Schilsky; Ev 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB